Cannabis Law Report

AUGUST 1, 2022

Love it or hate it, social media can be a powerful tool for education and data collection.

Education 52

Education Access Media Data 52

Cannabis Law Report

NOVEMBER 10, 2019

Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals. We interviewed all major sources to collect and certify qualitative and quantitative information and to determine future prospects. Insys Therapeutics.

Pharmaceutical 45

Pharmaceutical Research and Development Data Business 45

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

FEBRUARY 5, 2022

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Experience in project management.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

DECEMBER 15, 2021

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Experience in project management.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

SEPTEMBER 14, 2021

This alliance is just the first step in a larger movement to co-create a future where consumers have access to trusted cannabinoid products that fully deliver on their potential to help people live healthier, fuller lives.”. Step five: The OBX and Radicle Science validated product is sent to production. About Open Book Extracts.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

DECEMBER 7, 2021

Our audacious mission is to create the new standard of trust and transparency consumers deserve and healthcare providers demand on these widely accessible potential therapies. The large scale and intentional heterogeneity of our studies can transform these consumer health products into democratized precision solutions.”.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

United Patients Group

MAY 17, 2023

collecting items related to trains). Currently, medical cannabis is still federally illegal here in the US and not fully approved for safe and legal access in many countries around the globe. Emotions and Behaviors Autism spectrum disorder (ASD) is a spectrum disorder that affects people in different ways.

Sleep 81

Sleep Cannabinoids Patients CBD 81

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

SEPTEMBER 2, 2021

The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

AUGUST 3, 2021

ADCL’s solution includes the use of subcontractor CLEARED4’s health verification platform for appointments, sample tracking, and value-add services of campus access management. Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Visit adnas.com for more information.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0 Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

NOVEMBER 5, 2021

Sample collection for weekly COVID-19 pooled testing can be performed in-person (supervised) or via self-collection kits 1. Negative testing results yield a ‘green pass’ via CLEARED4 that is texted to the employee’s smartphone that authorizes access to corporate facilities. Dr. James A. About Applied DNA Sciences.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 8, 2019

AJEM’s mission is to create, collect, and disseminate credible cannabis research data. 2 Advancements in understanding the ECS have not been overlooked by the general public, which has demanded both answers about cannabis as a medicine and access to it. Accessed October 12, 2019. Accessed September 23, 2019.[link]

Medicine 59

Medicine Research and Development Food Cannabinoids 59

Cannabis Law Report

MARCH 2, 2020

to my knowledge, there are no state-governed collection programs built into medical cannabis policy, compliance, legal or tax frameworks, or end user means of disposal. Of course there are states that provide more access to cannabis waste recycling, such as California. We can always hope. In the U.S.,

Vaping 59

Vaping Collective Research and Development Packaging 59

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 30, 2019

Like others, Dr. Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Patient and physician are on this rocky journey together, for better or worse. . through international sources, namely Israel. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

SEPTEMBER 23, 2019

of Tax and Fee Administration [‘CDTFA”] could have done to be more efficient and effective at collecting state level cannabis taxes [See Cannabis Tax Calculation Example , Collecting Reporting – Remitting Tax and CCT CET – Responsible Persons. We have written extensively about steps that the California Dept.

Legislation 40

Legislation Research and Development Programs Collective 40

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. iv Named-patient and compassionate use proceduresThe TG Act provides mechanisms that allow individuals to gain limited access to UTGs (defined in Section II.iii). The institution at which the trial will be conducted gives the final approval.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

SMPL

MAY 26, 2020

And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

AUGUST 30, 2019

The US Department of Agriculture (USDA) has released new data indicating a substantial increase in the growth of US hemp production. Dubbed the the “Smart & Safe Arizona Initiative,” supporters of the effort must collect more than 237,645 valid signatures from voters by July 2, 2020, for the measure to be on the 2020 ballot.

Banking 45

Banking Research and Development Legislation Programs 45

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. Criterion 3. Criterion 5. Criterion 7.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. Criterion 3. Criterion 5. Criterion 7.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

JULY 24, 2022

The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 The collective term psychedelics or hallucinogens respectively (from Latin [h]al[l]ucinatio – thoughtless speech ) covers various substances that cause a perceptual and sensory disorder [2].

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

APRIL 16, 2019

In Washington State, a contract for traceability, such a cr itical part of Cannabis regulation, was awarded to BioTrack , a company already experienced across the US in tracking the movements of pharmaceutical products, seemingly a solid choice. Leaf Data Systems: Cannabis Software for Regulators. Cannabis Central LLC.

Seed-To-Sale 45

Seed-To-Sale Retail Packaging Pharmaceutical 45

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

AUGUST 19, 2019

The public health minister said that as of May 2019, only six NHS prescriptions had been written since the changes to the Regulations came into effect and ten private prescriptions were written between January 2019 and February 2019 according to the NHS Business Services Authority, which collects data on primary care.

Environment 45

Environment Food Seed-To-Sale Medicine 45